Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

FDA approves Fetzima for major depressive disorder in adults

July 26, 2013

Candesartan is as effective as propranolol for preventing migraine

July 26, 2013

Roche synthesizes novel TAAR1 ligands

July 26, 2013

Teva enters collaboration with Israeli academic institutions in neurodegenerative disease

July 26, 2013

Allergan prepares new sodium channel blockers

July 25, 2013

Valproic acid analogue evaluated for antimigraine potential

July 25, 2013

Northeastern University discloses new CB1 receptor modulators

July 25, 2013

Questcor to commence screening for phase II study of H.P. Acthar Gel in ALS

July 25, 2013

Sarepta plans eteplirsen NDA submission

July 25, 2013

New Alzheimer's disease model is based on N-truncated Abeta4-42 expression

July 25, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...